Why arent we doing a deal with lonza?surely lonza would be a...

Why arent we doing a deal with lonza?
surely lonza would be a perfect manufacturing partner for cymerus worldwide.

wot did wotton think about brookes ' strengthening the board' , comment, bit of an insult to the new jersey bio science sntrepreneur of the year
how is a director of Acrux and Actinogen becoming chairman, stengthening the board..ha!!

does the board realise they are supposed to be closing a non dilutive commercial deal, several in fact, after 7 years and validating Cymerus.

any chance of a big hitter joining the board, loaded up with shares or would this be too threatening to the status quo.

do they know who represents The Bank trust of japan, of both Fuji and Fidelity..and have fidelity been buying lately.

wot happened to Li Ka Shing of Rasko connection?

why didnt we hear about celularity again, no closure of that MOU.

can we expect another better offer from Sumitomo , if not why not?